DB
PTCT icon

Danske Bank’s PTC Therapeutics PTCT Stock Holding History

Danske Bank’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-200
Closed -$15.2K – 1475
2025
Q4 		$15.2K Sell
200
-18,574
-99% -$1.35M ﹤0.01% 1255
2025
Q3 		$1.15M Sell
18,774
-7,117
-27% -$371K ﹤0.01% 658
2025
Q2 		$1.26M Buy
+25,891
New +$1.23M ﹤0.01% 686
2024
Q2 		– Sell
-90,200
Closed -$2.62M – 1240
2024
Q1 		$2.62M Buy
+90,200
New +$2.53M 0.01% 645

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Danske Bank's PTCT Position: Q1 2026 in Review

Danske Bank sold out of PTC Therapeutics (PTCT) in Q1 2026, closing a stake of 200 shares — an estimated $15.2K sold.

Danske Bank first reported a position in PTCT in Q1 2024 and held it in 4 quarters. The position peaked at $2.62M in Q1 2024. 352 funds tracked by Wall St. Rank hold PTCT as of Q1 2026.

  • Danske Bank reported no remaining PTC Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Danske Bank sold 200 PTC Therapeutics shares in Q1 2026, an estimated $15.2K.
  • Danske Bank first reported a position in PTC Therapeutics in Q1 2024 and held it in 4 quarters.
  • Danske Bank's PTC Therapeutics position peaked at $2.62M in Q1 2024.
  • 352 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2026.

Based on Danske Bank's 13F filing for Q1 2026, filed 12 May 2026.